Business Wire

The newsfeed available here is provided by our content partner Business Wire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public. Business Wire is a subsidiary of the Warren Buffett Group Berkshire Hathaway.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 58
5.640,67 S&P · 23,68 Vola-Index · 96.340,51 BTC · 1,13419 EURUSD
System-State: Number of processed items 41.483 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
Business Wire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
US49177J1025
State: 07.05.2025 | 12AM
Do you already know our new terminal view? Click here.
FIGI: BBG01C79X561
KVUE
Kenvue Inc.
GICS: - · Sector: Consumer Defensive · Sub-Sector: Household & Personal Products
NAME
Kenvue Inc.
ISIN
US49177J1025
TICKER
KVUE
MIC
XNYS
REUTERS
KVUE.N
BLOOMBERG
KVUE US
Thu, 24.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Wed, 16.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on its common stock. This quarterly dividend is payable on May 28, 2025, to shareholders of record as of the close of business on May 14, 2025. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Wed, 16.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence (AI) technologies. These technologies include machine-enabled collab...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Wed, 19.03.2025       Kenvue
US49177J1025

Today, Kenvue Inc. (NYSE: KVUE) held a ribbon-cutting ceremony for its new 290,000 sq. ft. global headquarters in Summit, New Jersey. The Company – which marked the start of construction of its 100,000 sq. ft. state-of-the-art Science and Innovation Lab at a ceremony last year – has officially moved its headquarters from Skillman to Summit, New Je...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Fri, 07.03.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida. In findings from t...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Wed, 05.03.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero, Ltd., and Erica Mann, former President and Head of Bayer’s Consumer Health Division, to the Company’s Board of Directors (the “Board”). Additionally,...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 13.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available ...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 06.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024. “We delivered on our 2024 profit commitments despite headwinds that resulted in softer than expected sales growth and we enter 2025 as a more competitive company with stronger foundations,” said Thibaut Mongon, Chief E...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Wed, 05.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s (“Starboard”) submission of four nominees to stand for election to the Kenvue Board of Directors at Kenvue’s 2025 Annual Meeting of Shareholders: The Kenvue Board and managem...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 23.01.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from in...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 16.01.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the world’s largest pure-play consu...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Mon, 25.11.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut Mongon, Chief Executive Officer and Paul Ruh, Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time. A live webcast ...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 07.11.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal third quarter ended September 29, 2024. “During the third quarter, we continued to drive strong productivity and realize efficiency benefits from Our Vue Forward, which we are reinvesting behind our iconic brands to unleash the full potential of our business and...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 31.10.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Fri, 18.10.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its third quarter 2024 financial results before market open on November 7, 2024. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Thu, 17.10.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on November 27, 2024, to shareholders of record as of the close of business on November...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Mon, 23.09.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy, including releasing its first Task Force on Climate-related Financial Disc...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink
Fri, 23.08.2024       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Barclays Global Consumer Staples Conference in Boston, Massachusetts. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will participate in a fireside chat on Thursday, September 5, 2024, at ...
Read More
Kenvue
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.